A detailed history of Bessemer Group Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Bessemer Group Inc holds 75 shares of ACAD stock, worth $1,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares
75
Holding current value
$1,280
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.14 - $19.14 $1,135 - $1,435
75 New
75 $1,000
Q2 2022

Aug 10, 2022

SELL
$13.01 - $27.22 $2,484 - $5,199
-191 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$25.02 - $54.99 $4,778 - $10,503
191 New
191 $0
Q4 2020

Feb 09, 2021

BUY
$41.04 - $56.79 $0 - $0
0 New
0 $0

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.